Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 1
1987 1
1992 2
1993 1
1995 1
1996 1
1999 1
2000 1
2001 1
2002 1
2005 1
2009 3
2012 1
2013 3
2014 1
2015 2
2017 1
2018 1
2019 1
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Lifestyle Risk Factors for Overweight/Obesity in Spanish Children.
Miguel-Berges ML, De Miguel-Etayo P, Larruy-García A, Jimeno-Martinez A, Pellicer C, Moreno Aznar L. Miguel-Berges ML, et al. Among authors: pellicer c. Children (Basel). 2022 Dec 12;9(12):1947. doi: 10.3390/children9121947. Children (Basel). 2022. PMID: 36553390 Free PMC article.
Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry.
de Llano LP, Vennera Mdel C, Álvarez FJ, Medina JF, Borderías L, Pellicer C, González H, Gullón JA, Martínez-Moragón E, Sabadell C, Zamarro S, Picado C; Spanish Registry. de Llano LP, et al. Among authors: pellicer c. J Asthma. 2013 Apr;50(3):296-301. doi: 10.3109/02770903.2012.757780. Epub 2013 Jan 28. J Asthma. 2013. PMID: 23350994
Effectiveness of a new health care organization model in primary care for chronic cardiovascular disease patients based on a multifactorial intervention: the PROPRESE randomized controlled trial.
Orozco-Beltran D, Ruescas-Escolano E, Navarro-Palazón AI, Cordero A, Gaubert-Tortosa M, Navarro-Perez J, Carratalá-Munuera C, Pertusa-Martínez S, Soler-Bahilo E, Brotons-Muntó F, Bort-Cubero J, Nuñez-Martinez MA, Bertomeu-Martinez V, Gil-Guillen VF; PROPRESE research team. Orozco-Beltran D, et al. BMC Health Serv Res. 2013 Aug 2;13:293. doi: 10.1186/1472-6963-13-293. BMC Health Serv Res. 2013. PMID: 23915267 Free PMC article. Clinical Trial.
Omalizumab therapy in severe asthma: experience from the Spanish registry--some new approaches.
Vennera Mdel C, Pérez De Llano L, Bardagí S, Ausin P, Sanjuas C, González H, Gullón JA, Martínez-Moragón E, Carretero JA, Vera E, Medina JF, Alvarez FJ, Entrenas LM, Padilla A, Irigaray R, Picado C; Spanish Registry. Vennera Mdel C, et al. J Asthma. 2012 May;49(4):416-22. doi: 10.3109/02770903.2012.668255. Epub 2012 Mar 23. J Asthma. 2012. PMID: 22443408
[Economic cost of treating the patient with asthma in Spain: the AsmaCost study].
Martínez-Moragón E, Serra-Batllés J, De Diego A, Palop M, Casan P, Rubio-Terrés C, Pellicer C; por el Grupo de Investigadores del estudio AsmaCost. Martínez-Moragón E, et al. Among authors: pellicer c. Arch Bronconeumol. 2009 Oct;45(10):481-6. doi: 10.1016/j.arbres.2009.04.006. Epub 2009 Jun 13. Arch Bronconeumol. 2009. PMID: 19525051 Spanish.
26 results